Sanofi

Company Snapshot

Founded: 1994
Entity Type: Public
Employees: 82,878
Region: U.S.
Revenue: $44,458.3 Millions
Revenue Year: 2024
Segment: Biopharma segment
Headquarter: Paris, France
Key Geographics: U.S., Europe, Rest of the World

Company Overview

Sanofi is a global life sciences company committed to discovering, developing, and distributing safe and effective medicines. The company manufactures and markets pharmaceuticals, vaccines, and animal health products. The company has a wide global presence and dominates the U.S. and European markets. Sanofi operates primarily in two business segments: biopharma and consumer healthcare. For all geographic territories, the Biopharma operating segment comprises commercial operations and research, development, and production activities associated with Specialty Care, General Medicines, and Vaccine franchises. More than 180 countries can purchase Sanofi products, and the company operates in nearly 70 countries.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Sanofi In Reports

Global Markets for Infectious Disease Treatments

BCC Research Analyst provide a detail report on Therapies for Rheumatoid Arthritis market trends of therapies for rheumatoid arthritis with data from 2024, estimates from 2025, projections of compound annual growth...

Global Markets for Allergy Diagnostics and Treatments

BCC Research Market Report for allergy diagnostic and treatment market trends of allergy diagnostics and treatments with data from 2023, estimates from 2024, projections of CAGR through 2029 (forecast period 2024...

Global Thyroid Gland Disorders: Diagnostics and Treatment Market

Our detailed report on the Thyroid Gland Disorder Market trends It includes global revenue ($ Million) for the base year of 2023 and estimated data for the forecast period 2024 through 2029.

Company's Business Segments

  • Biopharma segment : Biopharma segment comprises Specialty Care, General Medicines and Vaccines businesses for example Dupixent, Aubagio, Myozyme, Fabrazyme, Cerezyme, Eloctate, Alprolix, Nexviazyme, Jevtana, Sarclisa, Kevzara, Cerdelga, Aldurazyme,Cablivi and others
  • Consumer Healthcare segment : The Consumer Healthcare operating segment comprises commercial operations relating to Consumer Healthcare products, Research, development and production activities and global support functions dedicated to the segment. for example AllergyCough, Cold and Flu, Pain, Care, Digestive, Wellness, Physical and Mental Wellness, Personal Care and Others

Applications/End User Industries

  • Diabetes Products Companies
  • Cardiovascular Diseases
  • Neurological Disorders
  • Pharmacists
  • Medical Professionals
  • Clinics
  • Public Health Organizations
  • Healthcare Policymakers
  • Vitamins Manufacturing
  • Supplements Manufacturing
  • Skincare Manufacturing
  • Clinical Trials
  • Scientific Research